As per the scope of the report, it covers kits, instruments, and consumables of the allergy in vitro tests, such as first-generation qualitative assays like (RAST), the second generation semi-quantitative IgE assays, and third-generation auto analyzers. Allergic diseases include anaphylaxis, food allergies, forms of asthma, conjunctivitis, eczema, eosinophilic disorders, and drug and insect allergies. Allergen-specific IgE antibody is the most common in vitro test for allergy and is used to diagnose type I hypersensitivity reactions to foods or reactivity to aeroallergens in patients.

Alzheimer's disease is a progressive, degenerative disorder that attacks the brain's nerve cells, or neurons, resulting in loss of memory, thinking, language skills, and behavioural changes. The market is anticipated to grow, driven by disease-modifying drugs, and the vast number of last-stage pipeline drugs. The market size provided in the report has been derived from the revenue generated by products and their distribution channel, considered in the scope of the report. For estimating the market size of the product, the average selling price (ASP) of a product in the region has been multiplied with the sales volume (new sales and replacement rate, based on the applicability).

Tuberculosis(TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies. The first line of treatment is mostly preferred and widely available across the world. However, with growing resistant to antibiotics, there is an increasing demand of innovative drug resistant TB medications to be widely available. These factors, along with others, drive the anti- tuberculosis therapeutics market.

The term biopharmaceutical refers to any biologically synthesized molecule that is used to treat or manage disorders. Biopharmaceutical products include (but are not limited to) monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, recombinant enzyme, synthetic immunomodulators, cell and gene therapies, and other products. The market estimation provided in the standard report is subject to the scope of the study, and may not be in line with the market estimates provided elsewhere.

The global bone and joint health ingredients market (henceforth referred to as the market studied) is expected to reach USD 3,345.33 million by 2023, at an estimated CAGR of 6.3% over the forecast period (2018-2023). The market studied is segmented based on the type, application, and geography. Based on the type of bone and joint health ingredients, there are calcium, vitamin D, vitamin K, magnesium, collagen, glucosamine, and chondroitin, which are commercially relevant. Based on the application, the market is segmented into dietary supplement and functional food & beverage. The functional food & beverage segment has started emerging as a popular medium to consume bone and joint health promoting ingredients, particularly in the developed markets of Europe and North America.

The report provides market dynamics and trends related to the global companion diagnostics market. In addition, it presents the market estimations and forecast of the market. The study estimates the revenue generated from the sales of companion diagnostics kits and does not include companion diagnostics service revenue. The valuations comprise revenue generated from companion diagnostics that are available for treatment of cancer, CNS disorders, infectious disease, and autoimmune disease. Furthermore, the report also excludes revenue generated from post-sale services of companion diagnostics. For the purpose of analysis, the global companion diagnostics market has been segmented based on technology type, indication, and region. The study estimates the revenue generated from the sales of companion diagnostic kits. On the basis of technology type, the market is categorized into immunohistochemistry, polymerase chain reaction (PCR), next generation sequencing (NGS), in situ hybridization, and others. Based on indication, the market is divided into oncology, neurology, and others. Oncology is further sub-segmented into lung cancer, colorectal cancer, breast cancer, blood cancer, and others. The report covers the revenue generated from the sales of products related to companion diagnostics systems offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.

The research process adopted for this study is a highly structured, two-stage process: size estimation of the review period and the market engineering for the forecast period, of the global-, country-, and segment-level data, which leads to the data generation process (DGP) for the studied variables. The size estimations are carried out through multiple bottom-up and top-down approaches. The bottom-up approach includes the examining of historical revenues of key players, studying the size of the applications, value and supply chain analysis, and end-user demand, which are then cross-validated against secondary and primary resources.

在“健康中国2030”国家战略下，社区卫生服务机构建设是我国医疗改革保基本、强基层、建机制目标的具体体现。从沈阳市社区卫生服务机构建设现状出发，深入剖析沈阳市社区卫生服务机构建设中的发展瓶颈，并提出对策建议，为完善沈阳市社区医疗卫生改革提供解决思路。